FDA Import Refusal 1FX-8099523-5/30002/1 — GLENMARK PHARMA LTD
The FDA refused shipment 1FX-8099523-5/30002/1 from GLENMARK PHARMA LTD (India) on May 15, 2026. The refused product falls under Drugs and Biologics — GLIMEPIRIDE (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- May 15, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61PCA31 GLIMEPIRIDE (ANTI-DIABETIC)
- Charges
- 75